Get the Blueprint

Manufacturing NewsTEG DailyNovember 14, 2026

November 14, 2026 · Monroe County · Story 1 of 3

Simtra Opens $250M Bloomington Expansion, Plans 18 Filling Lines by 2027

Daniel BurkePublished every day

Simtra BioPharma Solutions cut the ribbon November 9 on Building H, a 153,000-square-foot addition to its Bloomington campus that cost more than $250 million. The new space holds three isolator-based sterile filling lines, including two high-speed syringe lines and a vial line fed by three freeze-dryers. Simtra says it will grow from 11 filling lines to 18 across Bloomington and its Halle, Germany site by 2027, and it has already spent more than $150 million on a nearby Park Campus where it plans a high-potency line for antibody-drug conjugates.

That build-out is landing in the middle of a capacity race. Vetter Pharma already runs 20 lines, Thermo Fisher just bought a Patheon fill site in New Jersey, PCI Pharma is a year into a $1 billion expansion, and Grand Rapids-based GRAM is adding a fifth line for $100 million. Simtra's June alliance with MilliporeSigma bundles ADC drug substance and fill-finish work into a single contract, a structure that could keep competing contract manufacturers out of those programs through 2030. The state's own contribution to the project, $500,000 in READI 2.0 infrastructure funding against a $250 million investment, is a fraction of a percent. If Indiana wins the next round of this competition, it will be on the strength of what's already built here, not on what the state is willing to write a check for.

Impact
This isn't an isolated ribbon-cutting: Simtra is racing into capacity against Vetter Pharma's 20 lines, Thermo Fisher/Patheon's newly acquired Ridgefield, NJ site, PCI Pharma's $1 billion expansion, and Grand Rapids-based GRAM's $100 million fifth line, all competing for the same sterile-injectables demand wave. The bigger under-told story is Simtra's June 2025 alliance with MilliporeSigma, which bundles ADC drug-substance and fill-finish into one contract, a lock-in structure that could foreclose competing CDMOs from winning those programs before 2030, while Indiana's own READI 2.0 contribution (a $500,000 sewer-infrastructure assist against a $250 million investment, a 0.2% subsidy ratio) suggests the state's incentive competitiveness, not its existing asset base, is the weaker card in future recruiting fights.
Watch
Whether ADC/biologics sponsors currently filling only in Halle begin tech-transfer and process-validation work ahead of the Park Campus high-potency line's 2027 opening, the window where early movers gain a real time-to-market edge.
For the huddle

Do we or our customers have ADC or biologics programs that would benefit from locking in Simtra/MilliporeSigma capacity now, before the 2027 Park Campus window tightens for competitors?

Not directly, but if you supply packaging, controls, or skilled trades labor into the Bloomington life-sciences corridor, the capacity race among Simtra, PCI Pharma, and GRAM is worth tracking for subcontracting and hiring competition.

Sources

  1. Simtra opens $250 million-plus Bloomington building with three sterile filling lines · marketscale.com

Earlier coverage

From the brief, November 14, 2026

  1. Simtra Opens $250M Bloomington Expansion, Plans 18 Filling Lines by 2027
  2. Power Up ETG Cuts Indiana's Wage Threshold to 10%
  3. EPA Digs Up Lead From a Muncie Battery Plant That Closed in 1984

The whole day’s brief →

This story

Monroe CountyPlants Capex

Related

Manufacturers Energy Grant Program

Free for Monroe County manufacturers

Monroe County manufacturers receive free, ongoing energy auditing and cost control that reduces their energy bills and keeps them low, month after month. Every line item checked and validated, every opportunity found comes with a step-by-step guide to capture it.

Claim your GrantCheck out the program

EDCs: sponsor this program and it carries your organization's name For economic developers →